We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sarcoma/skin cancer/malignant melanoma
Digital Poster
Clinical
Outcomes of patients with brain-only metastatic melanoma, treated with stereotactic radiosurgery
Charlotte Dawson, United Kingdom
-209
Stereotactic body radiotherapy vs. metastasectomy for soft tissue and bone sarcoma lung metastases – a systematic review analyzing safety and efficacy
Lena Kretzschmar, Switzerland
-395
Early Clinical Experience of Lattice Radiotherapy (LRT) in Bulky, Unresectable Soft Tissue Tumours: A Single-Center Cohort from Oman
Khadiga Mohammed, New Zealand
-438
Hypofractionated preoperative radiotherapy ?in soft tissue sarcoma of the extremities and trunk: outcomes from a prospective phase II study
Anastasia Stergioula , Greece
-860
Impact of high-risk factors on outcomes in cutaneous squamous cell carcinoma treated with adjuvant radiotherapy
Charis Thompson, United Kingdom
-1636
Radiotherapy with nivolumab (RADNIV) as a rechallenge for heavily pretreated patients with metastatic malignant melanoma: a pilot study
Rafal Suwinski, Poland
-1829
Stereotactic radiotherapy for malignant melanoma brain metastases in the immunotherapy era and the response rates of non-irradiated lesions
Kerem Tas, Germany
-1833
The role of Radiotherapy in the multidisciplinary management of radiation-associated angiosarcoma of the breast: A referral center experience.
Albina Allajbej, Italy
-2337
Postoperative hypofractionated volumetric modulated radiation therapy with integrated simultaneous boost in soft tissue sarcomas
DANIELA MARIEL ANGEL SCHUTTE, Argentina
-2474
An Evaluation of Radiotherapy and Response in the Management of Perivascular Epithelioid Cell Tumors: A CanSaRCC Study
Reinhardt Krcek, Canada
-2597
Radiotherapy in squamous cell skin cancers: current practice and future directions
Hajer KAMMOUN Mnif , France
-3117
Skin radiotherapy planning: 2D photography and tracing paper vs 3D Mixed Reality (MR) headset and stylus.
Stephen Morris, United Kingdom
-3162
Explainable machine learning predictive model for treatment response after SBRT in melanoma brain metastases
Donato Pezzulla, Italy
-3226
Combination of Stereotactic Radiotherapy with Immunotherapy or TargetedTherapy for melanoma brain metastases.
Alessia Reali, Italy
-3274
Postoperative Radiotherapy for Extremity Soft Tissue Sarcoma: Minimal Late Toxicity and Preserved Functional Outcomes
Youngju Song, Korea Republic of
-3598
A Systematic Review of Radiation-Induced Skin Reaction Assessment in People with Skin of Colour
Naman Julka-Anderson, United Kingdom
-3795
Association between biopsy-to-surgery interval and disease-free survival in soft-tissue sarcoma treated with neoadjuvant radiotherapy
Frédéric CARLET, France
-4007
Clinical Outcomes and the Impact of Radiotherapy in Myxofibrosarcoma: Insights from a Retrospective Cohort
Daniela Greto, Italy
-4424
Preoperative Radiotherapy in Soft Tissue Sarcoma: Outcomes, Toxicities and Clinical Implications
Daniela Greto, Italy
-4432
Real-world outcomes of Cemiplimab in advanced cutaneous squamous cell carcinoma: a single-center audit of over 100 patients
Rebecca Shakir, United Kingdom
-4668
LATTICE Radiotherapy for Advanced Sarcomas: Feasibility, Efficacy and Safety in 21 Patients with No Therapeutic Alternative
Marie-Claude BISTON, France
-4733
Early Clinical Experience with HyperSight CBCT-Based Adaptive Radiotherapy for Extremity and Abdominopelvic Soft Tissue Sarcomas
Reinhardt Krcek, Canada
-4776
Prognostic factors and long-term outcomes in patients with melanoma brain metastases treated with radiosurgery
Enrico Pozzo, Italy
-4802
Radiation-induced sarcomas: clinicopathological patterns, treatment strategies, and survival outcomes from a single reference center
Isabel Miguel, Portugal
-5017
Outcomes in Primary Meningeal Ewing’s Sarcoma (PMES): Retrospective analysis of the INSTINCT study
JIFMI JOSE MANJALI, India
-5086
Phyllodes Tumors and Recurrence Risk: Durable Local Control after Postoperative Radiotherapy with Moderate Dose Escalation
Angel Montero, Spain
-5112
Merkel cell carcinoma: prevalence and impact of delayed presentation in an international aggregated 949-patient database
Kurian Joseph, Canada
-5171